AbCellera Biologics Inc Live Stock Price Today, Share Analysis and Chart

Name: AbCellera Biologics Inc: Is Infosys Ltd. worth buying?
Item: AbCellera Biologics Inc
Rating: 1.5518055
Author: Trendlyne DVM scores

Momentum Trap

about

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that ...

12.54 0.52 (4.33%)

357.66% Gain from 52W Low

4.7M

XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

8.0 / 100

Technically Bullish

71.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 33%

10 analysts

AbCellera Biologics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

AbCellera Biologics Inc Live Stock Price Today, Share Analysis and Chart

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that ...

357.66% Gain from 52W Low

SWOT Analysis

AbCellera Biologics Inc Live Price Chart

AbCellera Biologics Inc Live Price Chart